Intracerebral haemorrhage;Intrazerebrale blutungen

Fortschritte der Neurologie Psychiatrie

Volumn 75, Issue 2, 2007, Pages 107-122

  Koennecke, Hans Christian ^a   Kauert, A ^a  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIVITAMIN K; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LORAZEPAM; MANNITOL; MIDAZOLAM; PHENYTOIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VALPROIC ACID;

ALCOHOLISM; BRAIN HEMORRHAGE; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; EPILEPSY; HUMAN; PREVALENCE; PROGNOSIS; PROPHYLAXIS; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS;

ANTICOAGULANTS; CEREBRAL HEMORRHAGE; HUMANS; NEUROSURGICAL PROCEDURES; PROGNOSIS;

EID: 34247114589     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-944313     Document Type: Review

References (61)

1. Darby DG, Donnan GA, Saling MA et al. Primary intraventricular hemorrhage: clinical and neuropsychological findings in a prospective stroke series. Neurology 1988; 38: 68-75
2. Qureshi AI, Tuhrim S, Broderick JP et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344: 1450-1460
3. th ed. 2004: 327-376
4. Rothwell PM, Coull AJ, Silver LE et al. for the Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366: 1773-1783
5. Zhang LF, Yang J, Hong Z et al. Proportion of different subtypes of stroke in China. Stroke 2003; 34: 2091-2096
6. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Hypertension 1998; 31: 1223-1229
7. Segal AZ, Chiu RI, Eggleston-Sexton PM et al. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 1999; 18: 185-193
8. Ebrahim S, Sung J, Song Y-M et al. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. Brit Med J, 2006; 33: 22-22 originally published online 6 Jun 2006; doi:10.1136/bmj.38855.610324.80,
9. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278
10. th ed 2004: 693-705
11. Koennecke H-C. Cerebral microbleeds on MRI - Prevalence, associations, and potential clinical implications. Neurology 2006; 66: 165-171
12. Fazekas F, Kleinert R, Roob G et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999; 20: 637-642
13. Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1-5
14. Davis SM, Broderick J, Hennerici M et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175-1181
15. Mayer SA, Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol 2005; 4: 662-672
16. Zazulia AR, Diringer MN, Videen Tel al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001; 21: 804-810
17. Andrews BT, Chiles BW, Olsen WL, Pitts LH. The effect of intracerebral hematoma location on the risk of brainstem compression and on clinical outcome. J Neurosurg 1988; 69: 518-522
18. Gebel Jr JM, Jauch EC, Brott TG et al. Relative edema volume is a predictor of outcome in patients with hyper-acute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2636-2641
19. Qureshi AI, Safdar K, Weil J et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995; 26: 1764-1767
20. Berwaerts J, Dijkhuizen RS, Robb OJ et al. Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant related intracerebral hemorrhage. Stroke 2000; 31: 2558-2562
21. Broderick JP, Brott TG, Duldner JE et al. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993
22. Hemphill JC 3rd, Bonovich DC, Besmertis L et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891-897
23. Lisk DR, Pasteur W, Rhoades H et al. Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 1994; 44: 133-139
24. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med 1995; 23: 950-954
25. Weimar C, Benemann J, Diener H-C. Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry 2006; 77: 601-605
26. Bamford J, Sandercock P, Dennis M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project - 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53: 16-22
27. Juvela S. Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 1995; 52: 1193-1200
28. Fogelholm R, Murros K, Rissanen A, Avikainen S. Long term survival after primary intracerebral hemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry 2005; 76: 1534-1538
29. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001; 29: 635-640
30. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol2001; 13: 83-92
31. Passero S, Burgalassi L, D'Andrea P, Battistini N. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 1995; 26: 1189-1192
32. Schwab S, Hamann G, Busch E et al. Intrazerebrale Blutung. In: Diener HC, Kommission Leitlinien der DGN (Hrsg.). Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, 2005: 247-251
33. Arakawa S, Saku Y, Ibayashi S et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998; 29: 1806-1809
34. O'Donnell HC, Rosand J, Knudsen KA et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240-245
35. Osborn AG, Blaser SI, Salzman KI et al. Diagnostic imaging: Brain. Salt Lake City: Amirsys, 2004 1. 4: 8-9
36. Zhu XL, Chan MS, Poon WS. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 1997; 28: 1406-1409
37. Broderick JP, Adams Jr HP, Barsan W et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905-915
38. Schellinger PD, Jansen O, Fiebach JB et al. Standardized MRI stroke protocol: Comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999; 30: 765-768
39. Kidwell CS, Chalela JA, Saver JL et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004; 292: 1823-1830
40. Atlas SW, Mark AS, Grossman RI, Gomori JM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T: comparison with spin-echo imaging and clinical application. Radiology 1988; 168: 803-807
41. Jauch EC, Lindsell CJ, Adeoye O et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke, Jun, 2006 doi:10.1161/01.STR.0000229878.93759. a2,
42. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54: 354-361
43. Leira R, Davalos A, Silva Y et al. Early neurologic deterioration in intracerebral hemorrhage. Predictors and associated factors. Neurology 2004; 63: 461-467
44. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 2003; 61: 1351-1356
45. Poungvarin N, Bhoopat W, Viriyavejakul A et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987; 316: 1229-1233
46. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypothesis. Stroke 1995; 26: 1471-1477
47. Huttner HB, Schellinger PD, Hartmann M et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006; 37: 1465-1470
48. Sorensen B, Johansen P, Nielsen GL et al. Reversal of the international normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003; 14: 469-477
49. Huttner HB, Jüttler E, Hug A et al. Antikoagulanzien- assoziierte Hirnblutungen. Nervenarzt 2006; 77: 671-681
50. Ananthasubramaniam K, Beattie JN, Rosman HS et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 2001; 119: 478-484
51. Butler AC, Tait RC. Restarting antikoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow up. Br J Haematol 1998; 103: 1064-1066
52. Leker RR, Abramsky O. Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 1998; 50: 1489-1491
53. Gage BF, Watermann AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke - Results from the national registry of atrial fibrillation. JAMA 2001; 28: 2864-2870
54. Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000; 31: 123-127
55. Eckman MH, Rosand J, Knudsen KA et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003; 34: 1710-1716
56. Viswanathan A, Rakich SM, Engel C et al. Antiplatelet use after intracerebral hemorrhage. Neurology 2006; 66: 206-209
57. Passero S, Rocchi R, Rossi S et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002; 43: 1175-1180
58. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001; 42: 515-524
59. Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387-397
60. Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology 1998; 50: 519-523
61. Mayer SA, Brun NC, Begtrup K et al. for the recombinant activated factor VII intracerebral hemorrhage trial investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-785